Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 14 hours ago
Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial miss
about 14 hours ago
Following a phase 3 knee osteoarthritis failure that its CEO acknowledged caused...
Merck and Sarah Cannon team up to boost oncology trial efficiency
about 14 hours ago
Oncology R&D organization Sarah Cannon Research Institute (SCRI) announced a collaboration with...
Craif raises $33M to boost work on its urine test for cancer
about 20 hours ago
The AI biopharma Craif has raised $33 million in its series D...
BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZeneca
about 20 hours ago
BioMarin Pharmaceutical has agreed to buy Alesta Therapeutics for $275 million upfront...
Johnson & Johnson MedTech nabs Monarch Quest 3 update for lung cancer detection
about 20 hours ago
Johnson & Johnson MedTech has been handed its fourth major software launch...
Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win
about 23 hours ago
Amylyx Pharmaceuticals’ $35 million bet on the GLP-1 receptor antagonist avexitide appears...
Leo ‘really strengthening’ pipeline with $435M deal for Tanabe rare skin disease drug awaiting FDA nod
1 day ago
Leo Pharma is sticking to its mission of strengthening its pipeline in...
Regeneron ends eye disease trial for anti-CD3 antibody following safety review
1 day ago
Regeneron has hit the brakes on the phase 1/2a trial for an...
Merck KGaA lays off 20 staffers in latest blow to US research team
1 day ago
The Massachusetts research site for Merck KGaA’s North American division, EMD Serono...
Slate uses Fulcrum to vault onto Nasdaq with $245M financing for migraine trials
2 days ago
Slate Medicines is hurtling toward a Nasdaq listing, securing a reverse merger...
Evaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate
2 days ago
Evaxion has scrapped a next-gen solid tumor vaccine in order to channel...
Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vague
2 days ago
Antibody platform business OmniAb continues to rack up the Big Pharma partnerships...